Authors: Cutuli, B Borel, C Dhermain, F Magrini, SM Wasserman, TH Bogart, JA Provencio, M de Lafontan, B de la Rochefordiere, A Cellai, E Graic, Y Kerbrat, P Alzieu, C Teissier, E Dilhuydy, JM Mignotte, H Velten, M

Citation: B. Cutuli et al., Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases, RADIOTH ONC, 59(3), 2001, pp. 247-255

Authors: Mauriac, L Blanc-Vincent, MP Luporsi, E Cutuli, B Fourquet, A Garbay, JR Giard, S Spyratos, F Zafrani, B Dilhuydy, JM

Citation: L. Mauriac et al., Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer, B CANCER, 87(6), 2000, pp. 469-490

Authors: Dilhuydy, JM Monira, MH Perrie, N Frezet, O Prince, G

Citation: Jm. Dilhuydy et al., Evaluation of the first social consultation in oncology: a series of 200 cases, B CANCER, 87(4), 2000, pp. 348-354

Authors: Mauriac, L MacGrogan, G Avril, A Durand, M Floquet, A Debled, M Dilhuydy, JM Bonichon, F

Citation: L. Mauriac et al., Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: Aunicentre randomized trial with a 124-month median follow-up, ANN ONCOL, 10(1), 1999, pp. 47-52

Authors: Marchal, C Weber, B de Lafontan, B Resbeut, M Mignotte, H du Chatelard, PP Cutuli, B Reme-saumon, M Broussier-leroux, A Chaplain, G Lesaunier, F Dilhuydy, JM Lagrange, JL

Citation: C. Marchal et al., Nine breast angiosarcomas after conservative treatment for breast carcinoma: A survey from French Comprehensive Cancer Centers, INT J RAD O, 44(1), 1999, pp. 113-119

Authors: Chomy, F Mauriac, L Dilhuydy, JM

Citation: F. Chomy et al., Timing of adjuvant chemotherapy in women undergoing breast-conserving surgery, CHALLENGES IN BREAST CANCER, 1999, pp. 205-212